- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future nanoparticle vaccines for COVID-19
Authors
Keywords
nanoparticle vaccine, COVID-19 vaccine, SARS-CoV-2, neutralizing antibody, protein nanoparticle
Journal
EBioMedicine
Volume 74, Issue -, Pages 103699
Publisher
Elsevier BV
Online
2021-11-19
DOI
10.1016/j.ebiom.2021.103699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
- (2021) Yin-Feng Kang et al. ACS Nano
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
- (2021) Philip J.M. Brouwer et al. CELL
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
- (2021) Cyrielle Fougeroux et al. Nature Communications
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
- (2021) Yongping Yang et al. Vaccines
- Recombinant protein vaccines, a proven approach against coronavirus pandemics
- (2021) Jeroen Pollet et al. ADVANCED DRUG DELIVERY REVIEWS
- Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
- (2021) Wenjun Wang et al. Cellular & Molecular Immunology
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity
- (2021) Mai N. Vu et al. Advanced Healthcare Materials
- Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs
- (2021) Sankar Renu et al. Frontiers in Immunology
- Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
- (2021) Rui Wang et al. GENOMICS
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Mix-and-match COVID vaccines trigger potent immune response
- (2021) Ewen Callaway NATURE
- Quadrivalent influenza nanoparticle vaccines induce broad protection
- (2021) Seyhan Boyoglu-Barnum et al. NATURE
- Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
- (2021) Brian J. Ward et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
- (2021) Linling He et al. Science Advances
- A global database of COVID-19 vaccinations
- (2021) Edouard Mathieu et al. Nature Human Behaviour
- Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
- (2021) Thai Thanh Hoang Thi et al. Vaccines
- T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
- (2021) Stanley C. Jordan et al. Cellular & Molecular Immunology
- Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
- (2021) Bin Zheng et al. CHEMICAL ENGINEERING JOURNAL
- Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink
- (2021) Kimberly G. Blumenthal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices
- (2021) Oscar A. Ortega-Rivera et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
- (2021) Talia Kustin et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
- (2021) Anne-Catherine Fluckiger et al. VACCINE
- Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
- (2021) David Hillus et al. Lancet Respiratory Medicine
- 564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
- (2021) M G Joyce et al. Open Forum Infectious Diseases
- The promise of mRNA vaccines: a biotech and industrial perspective
- (2020) Nicholas A. C. Jackson et al. npj Vaccines
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation
- (2020) Hannah G. Kelly et al. JCI Insight
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
- (2020) Jing Lu et al. CELL RESEARCH
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
- (2020) Sandhya Bangaru et al. SCIENCE
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maintaining Safety with SARS-CoV-2 Vaccines
- (2020) Mariana C. Castells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Immunological basis for enhanced immunity of nanoparticle vaccines
- (2019) Hannah G Kelly et al. Expert Review of Vaccines
- Biodegradable polymers for modern vaccine development
- (2019) Rajendran JC Bose et al. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination
- (2018) Theodora Ulli Jordanka Bruun et al. ACS Nano
- Quantitation and Stability of Protein Conjugation on Liposomes for Controlled Density of Surface Epitopes
- (2018) Zhilin Chen et al. BIOCONJUGATE CHEMISTRY
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses
- (2017) Shridhar Bale et al. JOURNAL OF VIROLOGY
- Designing liposomal adjuvants for the next generation of vaccines
- (2016) Yvonne Perrie et al. ADVANCED DRUG DELIVERY REVIEWS
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Design of a hyperstable 60-subunit protein icosahedron
- (2016) Yang Hsia et al. NATURE
- Accurate design of megadalton-scale two-component icosahedral protein complexes
- (2016) J. B. Bale et al. SCIENCE
- Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation
- (2016) Rina F. Villar et al. Scientific Reports
- Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher
- (2015) Samuel C Reddington et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Accurate design of co-assembling multi-component protein nanomaterials
- (2014) Neil P. King et al. NATURE
- Ligation Strategies for Targeting Liposomal Nanocarriers
- (2014) Patricia Marqués-Gallego et al. Biomed Research International
- RNA mediated toll-like receptor stimulation in health and disease
- (2012) Alexander H. Dalpke et al. RNA Biology
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now